Evidence map›Paper›PMID 41696317›Full record

ArticleACS omega2026

Designing Bioconjugated Ti

Shivangee Rai, Avijit Pramanik, Olorunsola Praise Kolawole, Kaelin Gates, Trinity Stark, Zoe Edorodion, Sanchita Kundu, Audri Barua, Suraj Akula, Sanika Janorkar and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shivangee RaiDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.
Avijit PramanikDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.ORCID https://orcid.org/0000-0002-4623-2099
Olorunsola Praise KolawoleDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.
Kaelin GatesDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.
Trinity StarkDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.
Zoe EdorodionDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.
Sanchita KunduDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.ORCID https://orcid.org/0000-0002-9843-0476
Audri BaruaDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.
Suraj AkulaDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.
Sanika JanorkarDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.
Padmaja R VedalaDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.
Fengxiang X HanDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.ORCID https://orcid.org/0000-0001-5135-3031
Paresh Chandra RayDepartment of Chemistry and Biochemistry, Jackson State University, Jackson, Mississippi 39217, United States.ORCID https://orcid.org/0000-0001-5398-9930

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since NIR-II (1000-1700 nm) imaging offers deeper tissue penetration, improved resolution, and higher signal-to-background ratios, development of two-photon excitation NIR-II probes is very important for next-generation bioimaging. Triple-negative breast cancer (TNBC) is inherently aggressive, with poor prognosis and therapeutic resistance, where two-photon diagnostics using the NIR-II probe are very important for effective disease monitoring and management. Herein, we report on the design of strong quantum-confined bioconjugated Ti

Identifiers

PMID41696317
PMCPMC12902965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.